Health ❯ Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Clinical Trials Drug Safety Weight Loss Weight Loss Drugs Cancer Treatment Drug Regulation Medications

Novo Nordisk Threatens Legal Action After Hims & Hers Unveils $49 Compounded Copy of Wegovy Pill

The clash follows FDA warnings about compounded GLP-1 marketing, with the legality of mass-produced oral copies unresolved.

White House Launches TrumpRx.gov, a Portal to Discounted Prescription Drugs

Landmark Lancet Review Finds Statins Do Not Cause Most Listed Side Effects

Honey Energy Supplement Recalled After FDA Finds Undeclared ED Drug

Stories older than 24h

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Intranasal Antibody Shows Flu Protection in Early Trial, Animal Studies

Novo Nordisk Forecasts Up to 13% 2026 Sales and Profit Decline as U.S. Price Cuts Bite

NBC Sells Out Super Bowl LX Ads at Record Rates

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

Merck Beats Q4 Forecasts as 2026 Guidance Trails Estimates on Patent Losses

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Oral Semaglutide Cuts Serious Heart-Failure Events 22% in Type 2 Diabetes With Heart Failure

CagriSema Beats Semaglutide on HbA1c and Weight at 68 Weeks in Type 2 Diabetes Trial

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

Frankfort’s First Medical Cannabis Dispensary Opens as Kentucky’s Fifth

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

EMA Panel Backs Conditional EU Approval for Rezurock in Chronic GvHD

Aspirin Started After 70 Fails to Prevent Cancer, Shows Higher Cancer Deaths During Trial

CMS Names 15 Drugs for 2028 Medicare Price Talks, First List to Include Part B Treatments